| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.6M | -30.9% |
| SG&A Expense | $10.3M | -40.0% |
| Operating Income | -$19.9M | +35.9% |
| Income Tax | $0 | — |
| Net Income | -$20.9M | +39.7% |
| EPS (Basic) | -$12.59 | +80.5% |
| EPS (Diluted) | -$12.59 | +80.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.2M | +396.6% |
| Current Assets | $4.4M | +162.3% |
| Total Assets | $12.2M | +1.7% |
| Current Liabilities | $20.4M | +53.4% |
| Total Liabilities | $21.3M | +20.0% |
| Stockholders' Equity | -$9.1M | -57.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.2M | +10.6% |
| Capital Expenditures | $207K | -95.8% |
| Investing Cash Flow | -$207K | +95.8% |
| Financing Cash Flow | $24.0M | +514.7% |
| Free Cash Flow | -$21.4M | +25.1% |